FindTrial
Sign In

Feasibility of incremental shuttle walk test in type 2 diabetes patients

Reliability and Validity of Incremental Shuttle Walk Test In Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023465
Enrollment
50
Registered
2020-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Centre for physiotherapy and rehabilitation sciences Jamia Millia Islamia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.T2DM diagnoses according to American Diabetes Association, 2013(A fasting plasma glucose level of 126 mg/dL (7.0 mmol/L) or higher, or. A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75-g oral glucose tolerance test) 2. To be able to walk independently without pain or a walking aid

Exclusion criteria

Exclusion criteria: 1.T2DM-related complication (i.e, severe neuropathy, nephropathy, or retinopathy) 2. Uncontrolled diabetes (blood sugar levels are above recommended target ranges including an A1C level above 7.0%) 3.History of cognitive impairment, severe heart and liver or kidney disease

Design outcomes

Primary

MeasureTime frame
Reliability Validity Physiological Responses Quality of life Diabetes distress scale Autonomic responsesTimepoint: Pre and Post Test—

Secondary

MeasureTime frame
Physiological Responses Quality of life Diabetes distress scale Autonomic responsesTimepoint: Pre and Post test—

Countries

India

Contacts

Public ContactDr Adila Parveen

Jamia Milllia Islamia

adilaprvn@gmail.com8587868142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026